Corneal allograft rejection in rabbits

Area of Science:

• Immunology
• Ophthalmology
• Transplantation

Background:

• Corneal graft rejection remains a significant challenge in transplantation.
• T-cell mediated immune responses are critical in graft rejection.
• Novel therapeutic strategies are needed to improve corneal allograft survival.

Purpose of the Study:

• To evaluate the therapeutic efficacy of a monoclonal antibody conjugated with ricin A-chain.
• To assess the antibody-ricin conjugate's effect on corneal graft rejection in a rabbit model.

Main Methods:

• A phase I study was conducted using a rabbit corneal allograft model.
• Corneal allografts were exchanged between Dutch and New Zealand rabbits.
• Animals received topical or retrobulbar cyclosporine, or subconjunctival/intravenous F(ab')2-ricin conjugate.

Main Results:

• Untreated rabbits experienced graft rejection within 16-22 days.
• Topical or retrobulbar cyclosporine delayed graft rejection.
• Neither subconjunctival murine anti-rabbit T cell monoclonal antibody nor the F(ab')2-ricin conjugate prevented rejection.

Conclusions:

• The tested anti-T cell monoclonal antibody conjugated with ricin A-chain was not effective in preventing corneal graft rejection in this model.
• Further research may be needed to optimize antibody-ricin conjugates or explore alternative therapeutic targets.